Twelve weeks posttreatment follow-up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin.

Source:http://linkedlifedata.com/resource/pubmed/id/20069649

Download in:

View as

General Info

PMID
20069649